COVID-19 in Adults With Hypertrophic Cardiomyopathy

Background: Individuals with cardiovascular disease are considered high risk for severe COVID-19. However, the clinical impact of COVID-19 in patients with hypertrophic cardiomyopathy (HCM) is unknown. The purpose of this study was to describe the clinical course and outcomes of COVID-19 in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Arabadjian, Milla E., Reuter, Maria C., Stepanovic, Alexandra, Sherrid, Mark V., Massera, Daniele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630625/
https://www.ncbi.nlm.nih.gov/pubmed/34859067
http://dx.doi.org/10.3389/fcvm.2021.745790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630625/
https://www.ncbi.nlm.nih.gov/pubmed/34859067
http://dx.doi.org/10.3389/fcvm.2021.745790

Ejemplares similares